AI Buyer Insights:

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Michelin, an e2open customer evaluated Oracle Transportation Management

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Michelin, an e2open customer evaluated Oracle Transportation Management

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

List of TCS ADD Customers

Apply Filters For Customers

Logo Customer Industry Empl. Revenue Country Vendor Application Category When SI Insight
The Janssen Pharmaceutical Companies of Johnson & Johnson Life Sciences 25000 $20.0B United States Tata Consultancy Services TCS ADD Clinical Trial Management 2017 n/a
Showing 1 to 1 of 1 entries

Buyer Intent: Companies Evaluating TCS ADD

ARTW Buyer Intent uncovers actionable customer signals, identifying software buyers actively evaluating TCS ADD. Gain ongoing access to real-time prospects and uncover hidden opportunities.

Discover Software Buyers actively Evaluating Enterprise Applications

Logo Company Industry Employees Revenue Country Evaluated
No data found
FAQ - APPS RUN THE WORLD TCS ADD Coverage

TCS ADD is a Clinical Trial Management solution from Tata Consultancy Services.

Companies worldwide use TCS ADD, from small firms to large enterprises across 21+ industries.

Organizations such as The Janssen Pharmaceutical Companies of Johnson & Johnson are recorded users of TCS ADD for Clinical Trial Management.

Companies using TCS ADD are most concentrated in Life Sciences, with adoption spanning over 21 industries.

Companies using TCS ADD are most concentrated in United States, with adoption tracked across 195 countries worldwide. This global distribution highlights the popularity of TCS ADD across Americas, EMEA, and APAC.

Companies using TCS ADD range from small businesses with 0-100 employees - 0%, to mid-sized firms with 101-1,000 employees - 0%, large organizations with 1,001-10,000 employees - 0%, and global enterprises with 10,000+ employees - 100%.

Customers of TCS ADD include firms across all revenue levels — from $0-100M, to $101M-$1B, $1B-$10B, and $10B+ global corporations.

Contact APPS RUN THE WORLD to access the full verified TCS ADD customer database with detailed Firmographics such as industry, geography, revenue, and employee breakdowns as well as key decision makers in charge of Clinical Trial Management.